Diagnostic News and Research

RSS

T2 Biosystems relocates to new 20,000 sq.ft. facility in Lexington

T2 Biosystems, Inc., a company developing next-generation medical diagnostic products, today announced that it has relocated to a newly renovated 20,000 sq.ft. facility located in Lexington, MA.

10 Jan 2011

Neuroptix announces closing of $4 million Series C funding round

Neuroptix Corporation, a leading innovator in the early detection of Alzheimer's Disease through a non-invasive eye test, today announced that it has closed the first approximately $4 Million tranche of a Series C funding round, as the company continues clinical development of its diagnostic platform.

10 Jan 2011

Key Equipment Finance and Hitachi Medical Systems America enter new partnership

Key Equipment Finance, one of the nation's largest bank-held equipment finance companies and an affiliate of KeyCorp today announced that the company has entered into an exclusive, long term, program agreement with Hitachi Medical Systems America. Hitachi Medical Systems America is the U.S. distributor of Hitachi Medical Corporation's diagnostic imaging products.

10 Jan 2011

Researchers demystify death of brain cells in Parkinson's patients

Just 5 percent of Parkinson's disease cases can be explained by genetic mutation, while the rest have no known cause. But a new discovery by researchers at The University of Texas Health Science Center San Antonio may begin to explain why the vast majority of Parkinson's patients develop the progressive neurodegenerative disease.

10 Jan 2011

Lancet World Report examines health risks associated with inaccurate TB tests, WHO's upcoming recommendations

With "scores of commercial serology tests for tuberculosis ... being sold in high-burden countries," the "WHO is due to release a negative policy recommendation - the first of its kind for the organisation" - after several reviews have "indicated poor performance of these tests," Lancet World Report writes in a piece that documents the health risks associated with a growing number of inaccurate TB tests.

10 Jan 2011

USDTL launches two new tests for monitoring long-term alcohol exposure using fingernail, hair specimens

United States Drug Testing Laboratories launched two new tests for monitoring long-term alcohol exposure on Friday. Using fingernail and hair specimens, the new assay is the first and only test to report a donor's alcohol exposure for the past 90 days reliably.

10 Jan 2011

Specific silicon microdevices may provide new way to screen metastatic breast cancer cells

Research by engineers and cancer biologists at Virginia Tech indicate that using specific silicon microdevices might provide a new way to screen breast cancer cells' ability to metastasize.

9 Jan 2011

Entelos receives U.S. Patent for Predictive Toxicology for Biological Systems

Entelos, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,853,406 entitled "Predictive Toxicology for Biological Systems" to the Company.

9 Jan 2011

FDA grants marketing clearance for diaDexus's PLAC Test

diaDexus, a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced that the U.S. Food and Drug Administration has cleared for marketing the automated version of its proprietary PLAC® Test.

9 Jan 2011

Eyespot launches flagship retail store at Chestnut Hill Shopping Center

EyeSpot announces the opening of its flagship retail store at the Chestnut Hill Shopping Center located on Route 9 West. The store carries a wide selection of the finest eyewear brands and state-of-the-art diagnostic imaging technology.

9 Jan 2011

Simple Alzheimer’s disease test developed

The latest research has shown that a simple blood test could detect Alzheimer’s disease. Applying the same technology it could also detect hard-to-detect cancers and other diseases. The study reports appeared this Thursday in the journal Cell.

9 Jan 2011

Babies' brains process language the same way as adults

Babies, even those too young to talk, can understand many of the words that adults are saying - and their brains process them in a grown-up way.

7 Jan 2011

Impulse Monitoring announces acquisition of Great Lakes Intraoperative Monitoring

Impulse Monitoring, Inc. (IMI), a leading provider of intraoperative neurophysiologic monitoring (IONM) services to hospitals, today announced that it has acquired the assets of Great Lakes Intraoperative Monitoring, LP (GLIM), a subsidiary of Williamsville, NY-based Archer Medical Diagnostic Testing, Inc.

7 Jan 2011

Critical Diagnostics' high sensitivity Presage ST2 Assay receives CE Mark approval

Critical Diagnostics announced today that it has received CE (Conformité Européenne) Mark for its high sensitivity Presage ST2 Assay and is commencing commercialization in Europe. The product is indicated for use as an aid in risk stratification of patients with heart failure or acute coronary syndrome. This regulatory milestone marks the first time that an assay has become commercially available for the clinical measurement of the biomarker soluble ST2.

7 Jan 2011

Amorfix's AD diagnostic assay detects aggregated beta amyloid in spinal fluid

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced preliminary results indicating that their human Alzheimer's disease (AD) diagnostic assay can detect a signal from aggregated beta amyloid in the spinal fluid (CSF) from AD patients.

7 Jan 2011

BG Medicine enters agreement to develop galectin-3 test for Siemens' automated immunoassay platforms

BG Medicine, Inc. announced today that it has entered into an agreement with Siemens Healthcare Diagnostics Inc., a division of Siemens Healthcare, one of the world's largest suppliers of clinical diagnostics to the healthcare industry, for the development and commercialization of a galectin-3 test for Siemens' automated immunoassay platforms for clinical laboratories.

7 Jan 2011

Plexxikon, Genentech enter PLX4032 co-promotion agreement

Plexxikon, Inc., announced today that it has signed an agreement with Genentech to co-promote PLX4032 (RG7204) in the United States. PLX4032, an oral, novel kinase inhibitor that targets the oncogenic BRAF mutation, is being tested in late-stage clinical trials for the treatment of metastatic melanoma.

7 Jan 2011

Biomarker study yields diagnostic blood test candidate for detection of Alzheimer's disease

OPKO Health, Inc. today announced the publication of a biomarker study yielding its diagnostic blood test candidate for the detection of Alzheimer's disease.

7 Jan 2011

Lab21 acquires Microgen Bioproducts

Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine and clinical diagnostics, has announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests to identify diseases and organisms which pose a threat to health.

6 Jan 2011

Scientists develop novel technology to detect immune molecules specific to Alzheimer's disease

Scientists from the Florida campus of The Scripps Research Institute, have developed a novel technology that is able to detect the presence of immune molecules specific to Alzheimer's disease in patients' blood samples. While still preliminary, the findings offer clear proof that this breakthrough technology could be used in the development of biomarkers for a range of human diseases.

6 Jan 2011

Diagnostic News and Research

T2 Biosystems relocates to new 20,000 sq.ft. facility in Lexington

Neuroptix announces closing of $4 million Series C funding round

Key Equipment Finance and Hitachi Medical Systems America enter new partnership

Researchers demystify death of brain cells in Parkinson's patients

Lancet World Report examines health risks associated with inaccurate TB tests, WHO's upcoming recommendations

USDTL launches two new tests for monitoring long-term alcohol exposure using fingernail, hair specimens

Specific silicon microdevices may provide new way to screen metastatic breast cancer cells

Entelos receives U.S. Patent for Predictive Toxicology for Biological Systems

FDA grants marketing clearance for diaDexus's PLAC Test

Eyespot launches flagship retail store at Chestnut Hill Shopping Center

Simple Alzheimer’s disease test developed

Babies' brains process language the same way as adults

Impulse Monitoring announces acquisition of Great Lakes Intraoperative Monitoring

Critical Diagnostics' high sensitivity Presage ST2 Assay receives CE Mark approval

Amorfix's AD diagnostic assay detects aggregated beta amyloid in spinal fluid

BG Medicine enters agreement to develop galectin-3 test for Siemens' automated immunoassay platforms

Plexxikon, Genentech enter PLX4032 co-promotion agreement

Biomarker study yields diagnostic blood test candidate for detection of Alzheimer's disease

Lab21 acquires Microgen Bioproducts

Scientists develop novel technology to detect immune molecules specific to Alzheimer's disease

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News